(Q56554243)

15

0 references

Val Lewington

object named as

Val Lewington

12

0 references

author name string

Kristien Boelaert

2

0 references

Steve Colley

3

0 references

Carol Evans

4

0 references

Rhodri M Evans

5

0 references

Georgina Gerrard BA

6

0 references

Jackie Gilbert

7

0 references

Barney Harrison

8

0 references

Sarah J Johnson

9

0 references

Thomas E Giles

10

0 references

Laura Moss

11

0 references

Kate Newbold

13

0 references

Judith Taylor

14

0 references

John Watkinson

16

0 references

Graham R. Williams

Thyroid cancer epidemiology and prognostic variables

17

0 references

publication date

July 2014

0 references

published in

Clinical Endocrinology

0 references

volume

81

0 references

page(s)

1-122

0 references

cites work

1 reference

Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.

21 January 2018

1 reference

Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study

21 January 2018

1 reference

Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.

21 January 2018

1 reference

Thyroid Diseases after Treatment of Hodgkin's Disease

21 January 2018

1 reference

Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies

21 January 2018

1 reference

Thyroid cancer among young women related to prior thyroid disease and pregnancy history

21 January 2018

1 reference

Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies

21 January 2018

1 reference

Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.

21 January 2018

1 reference

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

21 January 2018

1 reference

Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.

21 January 2018

1 reference

Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients.

21 January 2018

1 reference

Pathomorphological findings in thyroid cancers of children from the Republic of Belarus: a study of 86 cases occurring between 1986 ('post-Chernobyl') and 1991

21 January 2018

1 reference

Diagnosis, treatment, and outcome of follicular thyroid carcinoma

21 January 2018

1 reference

Hürthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior

21 January 2018

1 reference

Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients

21 January 2018

1 reference

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

21 January 2018

1 reference

Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival

21 January 2018

1 reference

Natural history, treatment, and course of papillary thyroid carcinoma

21 January 2018

1 reference

Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database

21 January 2018

1 reference

Distant metastases in papillary thyroid cancer. A review of 91 patients

21 January 2018

1 reference

Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.

21 January 2018

1 reference

Prognostic nomograms to predict oncological outcome of thyroid cancers

21 January 2018

1 reference

Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients

21 January 2018

1 reference

Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome

21 January 2018

1 reference

Importance of clarifying patients' desired role in shared decision making to match their level of engagement with their preferences.

21 January 2018

1 reference

The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.

21 January 2018

1 reference

Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma

21 January 2018

1 reference

Lymph node ratio predicts recurrence in papillary thyroid cancer

21 January 2018

1 reference

PET/CT imaging of thyroid cancer

21 January 2018

1 reference

Management of simple nodular goiter: current status and future perspectives

21 January 2018

1 reference

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

21 January 2018

1 reference

Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules

21 January 2018

1 reference

Upper airways obstruction in 153 consecutive patients presenting with thyroid enlargement

21 January 2018

1 reference

Nodular thyroid disease. Evaluation and management

21 January 2018

1 reference

Controversies in the management of cold, hot, and occult thyroid nodules

21 January 2018

1 reference

Differentiation between benign and malignant solid thyroid nodules using an US classification system

21 January 2018

1 reference

New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid.

21 January 2018

1 reference

American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules

21 January 2018

1 reference

Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study

21 January 2018

1 reference

Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations

21 January 2018

1 reference

Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone?

21 January 2018

1 reference

US Features of thyroid malignancy: pearls and pitfalls

21 January 2018

1 reference

The usefulness of sonographic features in selection of thyroid nodules for biopsy in relation to the nodule's size.

21 January 2018

1 reference

Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?

21 January 2018

1 reference

Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study

21 January 2018

1 reference

Thyroid nodule size and prediction of cancer

21 January 2018

1 reference

The impact of thyroid nodule size on the risk of malignancy and accuracy of fine-needle aspiration: a 10-year study from a single institution

21 January 2018

1 reference

False negatives in thyroid cytology: impact of large nodule size and follicular variant of papillary carcinoma.

21 January 2018

1 reference

Reliability of fine-needle aspiration for thyroid nodules greater than or equal to 4 cm.

21 January 2018

1 reference

Partially cystic thyroid nodules: ultrasound findings of malignancy

21 January 2018

1 reference

Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours

21 January 2018

1 reference

Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review

21 January 2018

1 reference

Relationship between patterns of calcification in thyroid nodules and histopathologic findings

21 January 2018

1 reference

Evaluating thyroid nodules: predicting and selecting malignant nodules for fine-needle aspiration (FNA) cytology

21 January 2018

1 reference

Fine needle aspiration cytology in diagnosis and management of thyroid disease.

21 January 2018

1 reference

Fine-needle aspiration biopsy in the diagnosis and follow-up of thyroid nodules in childhood

21 January 2018

1 reference

Adenomatoid nodules are the main cause for discrepant histology in 234 thyroid fine-needle aspirates reported as follicular neoplasm

21 January 2018

1 reference

Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.

21 January 2018

1 reference

BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features.

21 January 2018

1 reference

The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines.

21 January 2018

1 reference

Encapsulated follicular variant of papillary thyroid carcinoma: fine-needle aspiration with ultrasound and histologic correlation of 41 cases

21 January 2018

1 reference

Reliability of benign fine needle aspiration cytology of large thyroid nodules

21 January 2018

1 reference

Factors affecting inadequate sampling of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules.

21 January 2018

1 reference

Comparison of palpation-guided versus ultrasound-guided fine-needle aspiration biopsies of thyroid nodules in an outpatient endocrinology practice.

21 January 2018

1 reference

Ultrasound-guided fine needle aspiration cytology in the diagnosis and management of thyroid nodules

21 January 2018

1 reference

Malignancy risk analysis in patients with inadequate fine needle aspiration cytology (FNAC) of the thyroid

21 January 2018

1 reference

Rapid on-site assessment of specimens by biomedical scientists improves the quality of head and neck fine needle aspiration cytology

21 January 2018

1 reference

Is there a role for on-site evaluation of thyroid fine needle aspiration to reduce the nondiagnostic rate?

21 January 2018

1 reference

Rapid onsite evaluation improves the adequacy of fine-needle aspiration for thyroid lesions: a systematic review and meta-analysis.

21 January 2018

1 reference

Routine on-site evaluation of specimen adequacy during initial ultrasound-guided fine needle aspiration of thyroid nodules: a cost-effectiveness analysis

21 January 2018

1 reference

Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer

21 January 2018

1 reference

Optimal indication of thyroglobulin measurement in fine-needle aspiration for detecting lateral metastatic lymph nodes in patients with papillary thyroid carcinoma

21 January 2018

1 reference

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

21 January 2018

1 reference

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules

21 January 2018

1 reference

Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA).

21 January 2018

1 reference

Clinical implications of pre-operative rapid BRAF analysis for papillary thyroid cancer

21 January 2018

1 reference

B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules

21 January 2018

1 reference

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer

21 January 2018

1 reference

Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.

21 January 2018

1 reference

BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population.

21 January 2018

1 reference

Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system.

21 January 2018

1 reference

Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy

21 January 2018

1 reference

Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules

21 January 2018

1 reference

Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules

21 January 2018

1 reference

Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration

21 January 2018

1 reference

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples

21 January 2018

1 reference

Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules.

21 January 2018

1 reference

Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.

21 January 2018

1 reference

Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.

21 January 2018

1 reference

Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration

21 January 2018

1 reference

BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles.

21 January 2018

1 reference

BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma

21 January 2018

1 reference

Does routine consultation of thyroid fine-needle aspiration cytology change surgical management?

21 January 2018

1 reference

Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy

21 January 2018

1 reference

Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions

21 January 2018

1 reference

US-guided fine-needle aspiration of thyroid nodules: indications, techniques, results.

21 January 2018

1 reference

Value of US correlation of a thyroid nodule with initially benign cytologic results

21 January 2018

1 reference

How to combine ultrasound and cytological information in decision making about thyroid nodules

21 January 2018

1 reference

Value of repeating a nondiagnostic thyroid fine-needle aspiration biopsy

21 January 2018

1 reference

Inadequate cytology in thyroid nodules: should we repeat aspiration or follow-up?

21 January 2018

1 reference

Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology

21 January 2018

1 reference

A large multicenter correlation study of thyroid nodule cytopathology and histopathology

21 January 2018

1 reference

Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?

21 January 2018

1 reference

The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification system.

21 January 2018

1 reference

Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.

21 January 2018

1 reference

Thy3 cytology: what to do next?

21 January 2018

1 reference

Fine-needle aspiration of the diffuse sclerosing variant of papillary thyroid carcinoma masked by florid lymphocytic thyroiditis; A potential pitfall: A case report and review of the literature

21 January 2018

1 reference

Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

21 January 2018

1 reference

Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular).

21 January 2018

1 reference

Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology.

21 January 2018

1 reference

The importance of surgeon experience for clinical and economic outcomes from thyroidectomy.

21 January 2018

1 reference

Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery

21 January 2018

1 reference

Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT.

21 January 2018

1 reference

Contribution of computed tomography to ultrasound in predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma.

21 January 2018

1 reference

Informed consent for elective surgery--what is best practice?

21 January 2018

1 reference

Is DVT prophylaxis necessary for thyroidectomy and parathyroidectomy?

21 January 2018

1 reference

Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations

21 January 2018

1 reference

Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.

21 January 2018

1 reference

Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer

21 January 2018

1 reference

Efficacy and safety of central compartment neck dissection for recurrent thyroid carcinoma

21 January 2018

1 reference

Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation

21 January 2018

1 reference

A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy

21 January 2018

1 reference

Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: an institutional experience of 1,945 cases.

21 January 2018

1 reference

Surgery for papillary thyroid carcinoma: is lobectomy enough?

21 January 2018

1 reference

Risk stratification of follicular variant of papillary thyroid carcinoma

21 January 2018

1 reference

Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer

21 January 2018

1 reference

Prognostic relevance of previous exposure to ionizing radiation in well-differentiated thyroid cancer.

21 January 2018

1 reference

Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence

21 January 2018

1 reference

Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer

21 January 2018

1 reference

Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer

21 January 2018

1 reference

Prophylactic central neck dissection for papillary thyroid cancer

21 January 2018

1 reference

Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma

21 January 2018

1 reference

In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival

21 January 2018

1 reference

Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma

21 January 2018

1 reference

A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

21 January 2018

1 reference

A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer

21 January 2018

1 reference

The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.

21 January 2018

1 reference

Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin

21 January 2018

1 reference

Sex is not an independent risk factor for survival in differentiated thyroid cancer

21 January 2018

1 reference

Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma

21 January 2018

1 reference

Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma

21 January 2018

1 reference

Prospective evaluation of total thyroidectomy versus ipsilateral versus bilateral central neck dissection in patients with clinically node-negative papillary thyroid carcinoma.

21 January 2018

1 reference

Ipsilateral and contralateral central lymph node metastasis in papillary thyroid cancer: patterns and predictive factors of nodal metastasis

21 January 2018

1 reference

Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.

21 January 2018

1 reference

American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer

21 January 2018

1 reference

Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer

21 January 2018

1 reference

Level VII is an important component of central neck dissection for papillary thyroid cancer.

21 January 2018

1 reference

Thyroid frozen section: supplementary or unnecessary?

21 January 2018

1 reference

Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary?

21 January 2018

1 reference

Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels

21 January 2018

1 reference

Follicular thyroid carcinoma: histology and prognosis

21 January 2018

1 reference

Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma.

21 January 2018

1 reference

Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?

21 January 2018

1 reference

Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer

21 January 2018

1 reference

Hurthle cell carcinoma: a population-level analysis of 3311 patients

21 January 2018

1 reference

Age and tumor size predicts lymph node involvement in Hürthle Cell Carcinoma

21 January 2018

1 reference

True vocal fold immobility in the setting of well-differentiated thyroid carcinoma: unusual illustrative cases and recommendations for operative strategy

21 January 2018

1 reference

Surgical management of tracheal shaving for papillary thyroid carcinoma with tracheal invasion

21 January 2018

1 reference

Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence, and cancer-specific survival

21 January 2018

1 reference

Primary thyroid lymphoma: a clinical review

21 January 2018

1 reference

Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.

21 January 2018

1 reference

Incidence and histopathological behavior of papillary microcarcinomas: study of 429 cases

21 January 2018

1 reference

Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up

21 January 2018

1 reference

Clinically unsuspected papillary microcarcinomas of the thyroid: a common finding with favorable biology?

21 January 2018

1 reference

Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience.

21 January 2018

1 reference

An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid

21 January 2018

1 reference

Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas

21 January 2018

1 reference

Treatment for microcarcinoma of the thyroid--clinical experience.

21 January 2018

1 reference

Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma

21 January 2018

1 reference

What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?

21 January 2018

1 reference

Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis

21 January 2018

1 reference

Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases

21 January 2018

1 reference

Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections

21 January 2018

1 reference

Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients

21 January 2018

1 reference

Prognostic factors in patients with papillary thyroid carcinoma

21 January 2018

1 reference

Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?

21 January 2018

1 reference

Treatment and prognostic factors of papillary thyroid microcarcinoma

21 January 2018

1 reference

Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases

21 January 2018

1 reference

Incidental and nonincidental papillary thyroid microcarcinoma

21 January 2018

1 reference

Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.

21 January 2018

1 reference

Thyroid papillary microcarcinoma: a descriptive and meta-analysis study

21 January 2018

1 reference

Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy

21 January 2018

1 reference

Prognostic parameters for recurrence of papillary thyroid microcarcinoma

21 January 2018

1 reference

Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?

21 January 2018

1 reference

'Aggressive papillary' thyroid microcarcinoma.

21 January 2018

1 reference

Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors.

21 January 2018

1 reference

Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer.

21 January 2018

1 reference

Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience

21 January 2018

1 reference

Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes

21 January 2018

1 reference

Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factor.

21 January 2018

1 reference

Classification of papillary thyroid microcarcinoma according to size and fine-needle aspiration cytology: Behavior and therapeutic implications.

21 January 2018

1 reference

Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients

21 January 2018

1 reference

Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature

21 January 2018

1 reference

Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size

21 January 2018

1 reference

Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.

21 January 2018

1 reference

Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy

21 January 2018

1 reference

Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features

21 January 2018

1 reference

Papillary thyroid microcarcinoma: incidence and prognostic factors.

21 January 2018

1 reference

The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer

21 January 2018

1 reference

Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases

21 January 2018

1 reference

Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis.

21 January 2018

1 reference

Desmoplastic stromal reaction in papillary thyroid microcarcinoma.

21 January 2018

1 reference

Thyroid hormone replacement after thyroid lobectomy

21 January 2018

1 reference

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer

21 January 2018

1 reference

131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review

21 January 2018

1 reference

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy

21 January 2018

1 reference

Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.

21 January 2018

1 reference

One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy

21 January 2018

1 reference

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer

21 January 2018

1 reference

Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal

21 January 2018

1 reference

Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity

21 January 2018

1 reference

Recombinant human thyroid-stimulating hormone to stimulate 131-I uptake for remnant ablation and adjuvant therapy

21 January 2018

1 reference

Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer

21 January 2018

1 reference

Strategies of radioiodine ablation in patients with low-risk thyroid cancer

21 January 2018

1 reference

Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis

21 January 2018

1 reference

Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?

21 January 2018

1 reference

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

21 January 2018

1 reference

Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma

21 January 2018

1 reference

A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer

21 January 2018

1 reference

Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake.

21 January 2018

1 reference

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

21 January 2018

1 reference

Radioiodine treatment for differentiated thyroid cancer.

21 January 2018

1 reference

21 January 2018

1 reference

Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis

21 January 2018

1 reference

Leukaemias and cancers following iodine-131 administration for thyroid cancer

21 January 2018

1 reference

Second primary malignancies in thyroid cancer patients

21 January 2018

1 reference

Second primary cancers in thyroid cancer patients: a multinational record linkage study

21 January 2018

1 reference

131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging

21 January 2018

1 reference

The role of recombinant human thyrotropin for diagnostic monitoring of patients with differentiated thyroid cancer.

21 January 2018

1 reference

Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine the

21 January 2018

1 reference

Role of SPECT/CT in differentiated thyroid cancer.

21 January 2018

1 reference

Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.

21 January 2018

1 reference

Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.

21 January 2018

1 reference

Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients

21 January 2018

1 reference

Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer

21 January 2018

1 reference

In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response

21 January 2018

1 reference

Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems

21 January 2018

1 reference

Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observation period

21 January 2018

1 reference

Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).

21 January 2018

1 reference

Papillary and follicular thyroid cancer: impact of treatment in 1578 patients

21 January 2018

1 reference

Differentiated thyroid cancer with extrathyroidal extension: prognosis and the role of external beam radiotherapy.

21 January 2018

1 reference

External beam radiotherapy in the management of differentiated thyroid cancer

21 January 2018

1 reference

External radiotherapy in thyroid cancers

21 January 2018

1 reference

Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience

21 January 2018

1 reference

Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment

21 January 2018

1 reference

Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation

21 January 2018

1 reference

Radiotherapy planning techniques for thyroid cancer

21 January 2018

1 reference

Palliation of Metastatic Bone Pain: Single Fraction versus Multifraction Radiotherapy – A Systematic Review of Randomised Trials

21 January 2018

1 reference

A Systematic Overview of Radiation Therapy Effects in Skeletal Metastases

21 January 2018

1 reference

Prospective study of perioperative factors predicting hypocalcemia after thyroid and parathyroid surgery

21 January 2018

1 reference

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 January 2018

1 reference

Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer

21 January 2018

1 reference

Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.

21 January 2018

1 reference

Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies

21 January 2018

1 reference

Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies.

21 January 2018

1 reference

Subclinical thyroid dysfunction and incident hip fracture in older adults

21 January 2018

1 reference

Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women.

21 January 2018

1 reference

Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study.

21 January 2018

1 reference

Thyroid-hormone therapy and thyroid cancer: a reassessment

21 January 2018

1 reference

Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer

21 January 2018

1 reference

Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer

21 January 2018

1 reference

Risk for fracture in women with low serum levels of thyroid-stimulating hormone

21 January 2018

1 reference

Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy

21 January 2018

1 reference

FRAX and the assessment of fracture probability in men and women from the UK

21 January 2018

1 reference

Papillary thyroid microcarcinomas: big decisions for a small tumor

21 January 2018

1 reference

Thyroid lobectomy for indeterminate FNA: not without consequences.

21 January 2018

1 reference

Detection and management of hypothyroidism following thyroid lobectomy: evaluation of a clinical algorithm.

21 January 2018

1 reference

Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm

21 January 2018

1 reference

Papillary thyroid cancer: time course of recurrences during postsurgery surveillance

21 January 2018

1 reference

Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).

21 January 2018

1 reference

Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin.

21 January 2018

1 reference

Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer

21 January 2018

1 reference

Management of low-risk well-differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin

21 January 2018

1 reference

Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin.

21 January 2018

1 reference

Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.

21 January 2018

1 reference

Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective

21 January 2018

1 reference

Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.

21 January 2018

1 reference

Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal.

21 January 2018

1 reference

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

21 January 2018

1 reference

An overview of the management of papillary and follicular thyroid carcinoma

21 January 2018

1 reference

Thyroid cancer: differentiated carcinoma

21 January 2018

1 reference

Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.

21 January 2018

1 reference

Differentiated thyroid cancer: "complete" rational approach

21 January 2018

1 reference

External beam radiotherapy for differentiated thyroid cancer

21 January 2018

1 reference

Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma

21 January 2018

1 reference

Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer

21 January 2018

1 reference

Approach to the thyroid cancer patient with bone metastases

21 January 2018

1 reference

Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.

21 January 2018

1 reference

Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.

21 January 2018

1 reference

Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid

21 January 2018

1 reference

Evaluation and comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET/CT imaging in well-differentiated thyroid cancer.

21 January 2018

1 reference

[Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].

21 January 2018

1 reference

Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan

21 January 2018

1 reference

Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation.

21 January 2018

1 reference

Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma

21 January 2018

1 reference

131I therapy for elevated thyroglobulin levels

21 January 2018

1 reference

Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin.

21 January 2018

1 reference

The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings

21 January 2018

1 reference

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

21 January 2018

1 reference

Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.

21 January 2018

1 reference

Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAF(V600E) mutation

21 January 2018

1 reference

Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions

21 January 2018

1 reference

Impact of pregnancy on prevalence of goitre and nodular thyroid disease in women living in a region of borderline sufficient iodine supply

21 January 2018

1 reference

Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum

21 January 2018

1 reference

Thyroid cancer in pregnancy

21 January 2018

1 reference

Radiation hazards in children - lessons from Chernobyl, Three Mile Island and Fukushima

21 January 2018

1 reference

Outcomes following thyroid and parathyroid surgery in pregnant women

21 January 2018

1 reference

Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies

21 January 2018

1 reference

A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors

21 January 2018

1 reference

The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism

21 January 2018

1 reference

Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism

21 January 2018

1 reference

Thyroid hormone early adjustment in pregnancy (the THERAPY) trial

21 January 2018

1 reference

Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer

21 January 2018

1 reference

The effect of subsequent pregnancy on patients with thyroid carcinoma apparently free of the disease

21 January 2018

1 reference

The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy

21 January 2018

1 reference

Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review

21 January 2018

1 reference

Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review

21 January 2018

1 reference

Clinical and economic outcomes of thyroid and parathyroid surgery in children.

21 January 2018

1 reference

Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma

21 January 2018

1 reference

Prognostic and predictive factors in endocrine tumours

21 January 2018

1 reference

Current practices in performing frozen sections for thyroid and parathyroid pathology

21 January 2018

1 reference

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine

21 January 2018

1 reference

Medullary thyroid cancer: management guidelines of the American Thyroid Association

21 January 2018

1 reference

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

21 January 2018

1 reference

Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.

21 January 2018

1 reference

The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients

21 January 2018

1 reference

Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment

21 January 2018

1 reference

Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer

21 January 2018

1 reference

Biological relevance of medullary thyroid microcarcinoma

21 January 2018

1 reference

Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level

21 January 2018

1 reference

Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels

21 January 2018

1 reference

Biomarker-based risk stratification for previously untreated medullary thyroid cancer

21 January 2018

1 reference

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

21 January 2018

1 reference

Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.

21 January 2018

1 reference

Current update on medullary thyroid carcinoma

21 January 2018

1 reference

Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.

21 January 2018

1 reference

Micromedullary thyroid cancer: how micro is truly micro?

21 January 2018

1 reference

Medullary thyroid microcarcinoma: a population-level analysis of 310 patients

21 January 2018

1 reference

Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis

21 January 2018

1 reference

Prediction of lateral lymph node metastases in medullary thyroid cancer

21 January 2018

1 reference

Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma

21 January 2018

1 reference

Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.

21 January 2018

1 reference

Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.

21 January 2018

1 reference

Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?

21 January 2018

1 reference

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

21 January 2018

1 reference

Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study

21 January 2018

1 reference

Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines

21 January 2018

1 reference

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

21 January 2018

1 reference

Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course

21 January 2018

1 reference

Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective

21 January 2018

1 reference

The management of advanced thyroid cancer

21 January 2018

1 reference

Calcitonin kinetics in the early postoperative period of medullary thyroid carcinoma

21 January 2018

1 reference

Postoperative calcitonin study in medullary thyroid carcinoma

21 January 2018

1 reference

Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis

21 January 2018

1 reference

Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.

21 January 2018

1 reference

The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.

21 January 2018

1 reference

Long-term outcome of reoperations for medullary thyroid carcinoma

21 January 2018

1 reference

Benefit-risk balance of reoperation for persistent medullary thyroid cancer

21 January 2018

1 reference

The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms

21 January 2018

1 reference

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.

21 January 2018

1 reference

Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial

21 January 2018

1 reference

Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotide

21 January 2018

1 reference

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial

21 January 2018

1 reference

Cabozantinib in progressive medullary thyroid cancer

21 January 2018

1 reference

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

21 January 2018

1 reference

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

Multiple endocrine syndrome type IIb in early childhood

21 January 2018

1 reference

Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene

21 January 2018

1 reference

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

21 January 2018

1 reference

RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors

21 January 2018

1 reference

Changing patterns of thyroid carcinoma

21 January 2018

1 reference

Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases

21 January 2018

1 reference

Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid

21 January 2018

1 reference

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies

21 January 2018

1 reference

Anaplastic thyroid carcinoma: pathogenesis and emerging therapies

21 January 2018

1 reference

A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature.

21 January 2018

1 reference

Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study

21 January 2018

1 reference

Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel's thyroiditis.

21 January 2018

1 reference

The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma

21 January 2018

1 reference

Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients.

21 January 2018

1 reference

Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients

21 January 2018

1 reference

Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid

21 January 2018

1 reference

Approach to the patient with anaplastic thyroid carcinoma

21 January 2018

1 reference

Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy

21 January 2018

1 reference

Results of combined treatment of anaplastic thyroid carcinoma (ATC)

21 January 2018

1 reference

Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?

21 January 2018

1 reference

Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens

21 January 2018

1 reference

Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery

21 January 2018

1 reference

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group

21 January 2018

1 reference

Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma

21 January 2018

1 reference

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study

21 January 2018

1 reference

Phase II trial of sorafenib in metastatic thyroid cancer

21 January 2018

1 reference

Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer

21 January 2018

1 reference

21 January 2018

1 reference

Quality of life in patients with thyroid cancer compared with the general population

21 January 2018

1 reference

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Associat

21 January 2018

1 reference

A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later

21 January 2018

1 reference

Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.

21 January 2018

1 reference

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

21 January 2018

1 reference

Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas

21 January 2018

1 reference

Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up

21 January 2018

1 reference

Can we interpret serum thyroglobulin results?

21 January 2018

1 reference

Laboratory services for thyroglobulin and implications for monitoring of differentiated thyroid cancer

21 January 2018

1 reference

Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer

21 January 2018

1 reference

Analytical error and interference in immunoassay: minimizing risk

21 January 2018

1 reference

Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer

21 January 2018

1 reference

Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring

21 January 2018

1 reference

Causes of discordance between thyroglobulin antibody assays.

21 January 2018

1 reference

Concordance between thyroglobulin antibody assays.

21 January 2018

1 reference

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update

21 January 2018

1 reference

Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?

21 January 2018

1 reference

Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests

21 January 2018

1 reference

Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin

21 January 2018

1 reference

Advances in the follow-up of differentiated or medullary thyroid cancer

21 January 2018

1 reference

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer

21 January 2018

1 reference

Serum tumour markers: how to order and interpret them

21 January 2018

1 reference

Previous thyroid disease and risk of thyroid cancer in Switzerland

21 January 2018

1 reference

A pooled analysis of thyroid cancer studies. V. Anthropometric factors

21 January 2018

1 reference

Biopsy of Thyroid Nodules: Comparison of Three Sets of Guidelines

21 January 2018

1 reference

Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation

21 January 2018

1 reference

Interobserver and Intraobserver Variation Among Experts in the Diagnosis of Thyroid Follicular Lesions With Borderline Nuclear Features of Papillary Carcinoma

21 January 2018

1 reference

Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma

21 January 2018

1 reference

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

21 January 2018

1 reference

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

21 January 2018

1 reference

The association of well-differentiated thyroid carcinoma with insular or anaplastic thyroid carcinoma; evidence for dedifferentiation in tumor progression

21 January 2018

1 reference

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

21 January 2018

1 reference

Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

21 January 2018

1 reference

Variation in survival of adult patients with thyroid cancer in Europe

21 January 2018

1 reference

What to do with incidental thyroid nodules on imaging? An approach for the radiologist

21 January 2018

1 reference

Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients

21 January 2018

1 reference

Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients

21 January 2018

1 reference

Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease

21 January 2018

1 reference

Incidental papillary microcarcinoma of the thyroid--factors affecting lymph node metastasis

21 January 2018

1 reference

Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests

21 January 2018

1 reference

The Predictive Value of the Fine-Needle Aspiration Diagnosis “Suspicious for a Follicular Neoplasm, Hürthle Cell Type” in Patients With Hashimoto Thyroiditis

21 January 2018

1 reference